Caregiver Stress, Mental Health, and Self-Efficacy in ADHD Households

NCT ID: NCT06994000

Last Updated: 2025-05-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigate the relationship between caregiver stress, mental health, and self-efficacy in families with children who have ADHD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A cross-sectional design was utilized, involving 160 caregivers from the Abdullah Al-Tamimi Autism Center in Unaizah, Saudi Arabia. Participants completed an online questionnaire that assessed sociodemographic information, caregiver stress (via the Kingston Caregiver Stress Scale), mental health (using the Mental Health Continuum-Short Form), and self-efficacy (measured by the General Self-Efficacy Scale).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ADHD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Descriptive Group

A convenience sample of 160 participants included caregivers of children diagnosed with ADHD (inattention, hyperactivity, or a combination thereof) by a psychiatrist, following the DSM-5 TR diagnostic criteria at neurodevelopmental centers in Saudi Arabia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

mothers, fathers, or grandparents who are involved in the child's primary care and are between the ages of 18 and 60

Exclusion Criteria

Caregivers who declined to participate in the current study, those who failed to complete the questionnaire, individuals not residing in the same household, and those not engaged in direct patient care
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alexandria University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Khedr

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Qassim University

Al Qassim, Al-Qassim Region, Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

607/46/4838

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Role of Coenzyme Q in ADHD in Children
NCT04216186 RECRUITING PHASE3